Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The best time to buy is now. positive PIII results eventual buyout. money in the bank
So he thinks he can make $4 if it hits his 75m MC. How short is he? 100 shares? He was digging, going back many years, attempting to boast his reason for being short.
One way to prove him wrong is to release some good data. We are overdue. Now would be a perfect time. Let's see the 15 and 18 month data.
It's an arbitrary date. I'm just thinking investors will get itchy if we don't hear anything in a couple of weeks. It may be 3 or 4 weeks but at some point people want to hear something and if we don't I feel the short term holders will sell.
I'm still holding my 1,000 trading shares I bought at 5.90. LOL!!
Hi Tom, it seems to me once the charts take a bearish tone we pop a little and just when it seems we may be in a billets cycle we go down.
I say we drift between 5.50 and 6.00 for another couple of weeks while we anticipate news. If no news by the week of June 5th, then I say we can drop to test the 4.95 by mid June.
Let's hope we hear something powerful in the next several weeks.
Agreed. After my last post I went back and reread and noticed the date (Feb 2016). So perhaps it means if data is consistent at time of application and last year's data when orphan status was requested.
Perhaps. It kind of read to me like conditional approval, where you get to go to market but have to continue validating with trial results. It doesn't say "at the time of application" it says "at the time of marketing authorization".
You may be right! What I was thinking, they submit data at the time of application and since the application can take six months they need to submit the (latest) data again at the authorization meeting (if there is a meeting) to ensure the data is consistent to what was previously provided. In any event, it seems like we are further along then most thought. Perhaps the reason for today's move with above average volume.
This assumption will need to be confirmed at the time of marketing authorisation, in order to maintain the orphan status
Perhaps it means we need to provide the latest trial updates a week prior to decision meeting to ensure current data is good as of the date of EMA submission. Just a guess.
I think it will come in shortly after we file with EMA. I doubt we will get a PR on the submission but will upon decision. My guess we will file by 7/1 and hope to hear about partner by 7/31.
This is one thing that makes me question their fairness. They wait until 10k is filed then issue options. Now we have to wait a full year to learn why. I'm certain they knew the options were going to be rewarded so why not disclose in this year's filing?
Also, the options awards are on an irregular schedule so it appears they are tied to some milestone. I don't object the awards, I would like to know what they were for? What milestone was reached? Was it recent patent? If so, then where is the patent PR? If patent milestone is significant then it should be in a PR. Things have been too quiet too long. The best argument for a good value partnership is to release data and get share price up. Higher share price equals higher partnership value.
Releasing data is not detriment partnership value. It's time.
Some offers at 8.50 Can we get past it?
Volume above 10 and 90 day average. Some strength last few minutes. Trading at highs of day. Would be nice to hear some news.
I use to work for a large corp (top 100) and we used the same tactic. The biggest benefit was it looked at all positions and adjusted salary/comp accordingly and reduced turnover significantly. Retaining ee's especially when you are small like ADXS goes a long way in attaining company goals. It's money well spent.
The real issue is you bought 4 years too early. So please get over it. Shareholder value creation will happen. Just not on your timetable.
And with the "share grab" he is going to be filthy rich while the rest of us just gets plan ol' rich.
Fbg, you're like a women you just can't let go. By the time this does hit you will most likely shorten your life by 20 years and not be able to enjoy the outcome. You need to find peace.
IBB up 1.6% and XBI up 1.9%. Good day for bios.
It would be nice to get back up to 6 today.
Sorry there was 10 patients. I was thinking nine.
It looks to me it was 100%. 8 of 9 complete response at 6 month sigmoidoscopy and #9 didn't have a sigmoidoscopy until one year and was clear.
If I'm not mistaken the latest 10Q says trials will start in 2nd half of 2017. Seems like timetables are always pushed out so I'm not expecting anything until Thanksgiving or later.
Why is it we haven't heard about the patent?
I do. I use to live in Calif. some think Calif will slip into the ocean but I think it will rise 100 ft. When the big one hits.
Yes, yes, yes and no
Let's hope we hit payday before they all happen.
We should be getting a PR right about now on the patent.
Maybe all retail is out but you and me and I doubt the tutes would bother.
If so, once they make it public than we should jump in share price. If BOD is placing that much emphasis on it then, surely the tutes are. Perhaps that's the delay in PR, they needed to get the options awarded first. Hmmmmm!
LOL!! I have a feeling both will hit big within a week of each other. It seems like it's heading that way.
If he exercised 450,000 shares at 5.92, the $2.664M goes to the company's coffers.
We don't need LPC. We just need Missling to exercise his options to fund the future!
Key word in Dan's comment "suggest" it will work!
Perhaps he mentioned Merck to place more pressure on Astra. Pressure as in "we may have another partner, Astra, so you better raise your stinking bid."
Your scenario would happen if they bought in a team with less talent than than the current team. I would hope a better (more knowledgeable) team would be the case. In any event I don't think either would happen. We are stuck until all the dust settles.
It took me over 5 years to get over the fact that I am "aiding the shorts" I do find it safer in that I get the appreciation when the stock runs (vs covered calls). And if/when it does run (and it will run) we will all be happy that shorts are helping propel the share price up.
I think DOC knows his last gift of shares are probably his last great gift. I think you are correct in something big happening. His pockets are sooo stuffed that he can't add anything so you might as well make it happen now.
It sounds like they (management) are a bit nervous. Perhaps they know some tutes are fed up with them and they are hoping to get retail on their side so they can enjoy another year of getting paid for miscalculating EVERYTHING. Someone needs to go to shake things up. I doubt the SP will go lower because of s shake up.
Take the BO price less the strike price I.e. 25 less 5 = 20, 25 less 7.50 = 17.50. Time premium will vanish in the event of a buyout and most likely the options will trade a little less than the examples I given. In the event of a BO, my experience has been (in several instances) it would be better to exercise the options and then sell the stock.
My take on options... my experience has been that I made more money writing calls than buying.
The problem with selling calls is you limit your upside if the stock runs. I found it more lucrative to loan out the shares and use the proceeds to add to my position. No limitations on profits when it runs.
With the possibility of news on 3 trials I wouldn't be writing calls now. Maybe dabble with the Jan '18s since we should get news on all three trials by then.
Not here. I'm voting against everything for the lack of consistency with PRs.
Perhaps short covering going into the weekend and/or someone expecting news next week. Today's volume already higher than 10 day MA.
Thank Mike. Today is turning out to be a touchy feely kind of day. The promise we can bring to those afflicted just brings tears to my eyes. The part that got me was when the mother said she wants to hear her daughter say I love you. As a parent, that part is just overwhelming.
We know it should work. Let's get started with the Rhett's trial. I hope the PK/PD data is not holding it up.
Bio, thanks for sharing. A truly touching story.
Happy Birthday Tom!!
FWIW,
I called IR since I didn't hear back from them yesterday. I actually spoke with Adam and he did say he passed my note onto Matthew. I received the standard reply "go to 10K". I stated the 10k does not provide the latest info. He said he understands my position and I need to reference 10k. I also mention why Rett trial pushed from Q2 to 2nd half? Same reply. I also asked a generic question if Australia had a "fast track" program similar to FDA. He initially replied the company is only concerned with the patients. Understandably. He didn't think the Aussie govt had something similar but urged me to research to ascertain the answer.
Adam did mention that Missling is the hardest working CEO he knows. I agreed with him and stated that perhaps he is trying to do everything and needs more help like Fadiran. I then asked how Fadiran name is pronounced and we were abruptly disconnected.
We just need to continue to be patient.
Good one Tom!! I'd admit I bought too early. That's how I came to own 20k shares (now 21k). :)
I still may sell the last 1k if and when we get to 6.41.
I think for my next 3 buys, they will be hypothetical to see if I could do better bottom picking.
Here's my first. Buy at 5.77 and then sell at 6.17.